Published in Diabetologia on December 01, 1986
Mathematical modeling and analysis of insulin clearance in vivo. BMC Syst Biol (2008) 0.94
Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy (1998) 3.20
Behavioral fluency: Evolution of a new paradigm. Behav Anal (1996) 2.74
Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A (2006) 2.60
Characterization of seven C-peptide antisera. Diabetes (1978) 2.29
Absorption of injected insulin. A clinical-pharmacological study. Acta Pharmacol Toxicol (Copenh) (1969) 2.07
Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med (1991) 1.93
The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Diabetologia (1978) 1.92
Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy. J Clin Microbiol (2000) 1.87
Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med (2006) 1.86
Bankart repair for anterior instability of the shoulder. Long-term outcome. J Bone Joint Surg Am (1997) 1.70
C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Diabetes (1977) 1.65
The right to effective education. Behav Anal (1991) 1.62
Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br Med J (Clin Res Ed) (1982) 1.61
Insulin pharmacokinetics. Diabetes Care (1984) 1.60
Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000. J Pediatr Gastroenterol Nutr (2003) 1.59
Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr (1992) 1.52
Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ (1995) 1.50
Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr (1994) 1.50
Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1990) 1.47
Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin. Br Med J (Clin Res Ed) (1985) 1.47
Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46
The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia (2005) 1.44
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol (1983) 1.43
Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients. Br Med J (1973) 1.43
Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest (1978) 1.42
Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes (1978) 1.41
Absorption of isophane (NPH) insulin and its clinical implications. Br Med J (Clin Res Ed) (1982) 1.40
Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand (1981) 1.40
Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr (1994) 1.34
Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol (Copenh) (1979) 1.28
Variation in 125I-insulin absorption and blood glucose concentration. Diabetologia (1979) 1.26
Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia (1983) 1.25
β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis (2010) 1.20
Evaluation of the hypotensive effect of beta-adrenergic blockade in hypertension. Acta Med Scand (1969) 1.16
Hypoglycemia in IDDM. Diabetes (1989) 1.15
The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients. J Intern Med (1990) 1.15
Cognitive function during hypoglycaemia in type I diabetes mellitus. Br Med J (Clin Res Ed) (1986) 1.15
Detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay, indirect immunofluorescence, and virus isolation: a comparative study. J Med Virol (1986) 1.15
Glycaemic threshold for changes in electroencephalograms during hypoglycaemia in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) (1988) 1.14
Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin. Hoppe Seylers Z Physiol Chem (1976) 1.13
Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes (1978) 1.11
A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood. J Diabetes Complications (2001) 1.10
Contribution of rhinoviruses to respiratory viral infections in childhood: a prospective study in a mainly hospitalized infant population. J Med Virol (1988) 1.09
Modeling absorption kinetics of subcutaneous injected soluble insulin. J Pharmacokinet Biopharm (1989) 1.09
Lipid metabolites and nitrogen balance after abdominal surgery in man. Br J Surg (1979) 1.08
Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab (1981) 1.08
Outcome of double-blind, placebo-controlled food challenge tests in 107 children with atopic dermatitis. Clin Exp Allergy (1999) 1.08
Thyroid, gastric and adrenal auto-immunity in diabetes mellitus. Acta Endocrinol (Copenh) (1973) 1.05
Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children. Acta Endocrinol (Copenh) (1983) 1.05
Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. Br Med J (1979) 1.04
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion? Lancet (1977) 1.04
Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract (2009) 1.04
Structured parent education in the management of childhood atopic dermatitis: the Berlin model. Patient Educ Couns (2000) 1.04
Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabet Med (2012) 1.04
Homogeneity in pattern of decline of beta-cell function in IDDM. Prospective study of 204 consecutive cases followed for 7.4 yr. Diabetes Care (1992) 1.03
Urinary excretion of free cortisol in impaired renal function. Acta Endocrinol (Copenh) (1975) 1.02
Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) (1993) 1.02
Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics. Diabetologia (1981) 1.01
Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract (2011) 1.01
Influence of smoking on insulin requirement and metbolic status in diabetes mellitus. Diabetes Care (1980) 1.01
Heterogeneity of circulating C-peptide. J Clin Endocrinol Metab (1977) 1.01
Clinical manifestations of respiratory tract infections due to respiratory syncytial virus and rhinoviruses in hospitalized children. Acta Paediatr Scand (1989) 1.01
Renal threshold for glucose in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract (1997) 1.00
B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment. Diabetologia (1977) 1.00
The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetologia (1982) 0.99
Endocrine emergencies. Hypoglycaemia. Baillieres Clin Endocrinol Metab (1992) 0.99
Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus. Lancet (2001) 0.99
Glucose tolerance in cystic fibrosis. Arch Dis Child (1991) 0.98
Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders. Metabolism (1990) 0.98
Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Acta Endocrinol (Copenh) (1988) 0.98
Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis. Pediatr Allergy Immunol (2001) 0.97
Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group. J Clin Endocrinol Metab (1994) 0.97
Nocturnal electroencephalogram registrations in type 1 (insulin-dependent) diabetic patients with hypoglycaemia. Diabetologia (1991) 0.96
ELISA for human proinsulin. Clin Chim Acta (1986) 0.96
Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia. Acta Endocrinol (Copenh) (1981) 0.95
Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med (1999) 0.95
Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care (1999) 0.95
Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatment. Acta Endocrinol (Copenh) (1980) 0.95
Impaired glucose tolerance and diabetes mellitus in elderly subjects. Diabetes Care (1987) 0.94
Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon. Diabetologia (1977) 0.94
Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem (1993) 0.94
Importance of insulin absorption, subcutaneous blood flow, and residual beta-cell function in insulin therapy. Acta Paediatr Scand Suppl (1980) 0.94
Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation. Clin Endocrinol (Oxf) (1976) 0.94
Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients. Diabetes Care (1987) 0.93
In vivo and in vitro studies on the residual allergenicity of partially hydrolysed infant formulae. Acta Paediatr (1999) 0.93
Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes (1989) 0.92
Reproducibility and reliability of hypoglycaemic episodes recorded with Continuous Glucose Monitoring System (CGMS) in daily life. Diabet Med (2005) 0.92
C-peptide: an index of insulin secretion. Diabetes Metab Rev (1986) 0.91
Controlled oral food challenges in children--when indicated, when superfluous? Allergy (2005) 0.91
Lower levels of circulating IGF-I in Type 1 diabetic women with frequent severe hypoglycaemia during pregnancy. Diabet Med (2008) 0.89
Insulin release and pancreatic insulin is reduced in young prediabetic BB rats. Acta Endocrinol (Copenh) (1986) 0.89
Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load. Diabetes (1991) 0.89
Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia (2002) 0.89
Effect of epidural analgesia on the glycoregulatory endocrine response to surgery. Clin Endocrinol (Oxf) (1976) 0.89